DeepCure

DeepCure is a next-generation biotech company using AI to accelerate the development of novel, first-in-class precision therapeutics. They focus on areas of unmet medical need, particularly in inflammation and immunology, and utilize a unique approach that combines AI-driven drug discovery, a massive chemical library, and a molecular foundry to automate the synthesis and assaying of compounds. This allows them to quickly identify and test potential drugs, pushing the boundaries of traditional drug development pipelines and ultimately bringing safer and more effective treatments to patients faster.

DeepCure is based in Boston, MA, and was founded at MIT by a world-class team of drug discovery and computer scientists. They have raised significant funding from investors such as Morningside, and their company culture is innovative and collaborative, valuing diversity and the unique contributions of each team member. This focus on innovation and collaboration is a key factor in DeepCure's ambition to revolutionize the way drugs are discovered and developed.

DeepCure offers flexible work hours and unlimited paid leave and sick time, demonstrating a commitment to employee well-being and work-life balance. This generous policy allows employees to manage their personal commitments and maintain a healthy work-life integration. The company also offers generous parental leave, contributing to a supportive and inclusive work environment.

DeepCure offers a comprehensive benefits package that focuses on employee well-being and professional development. This includes a competitive salary and equity grants, flexible work hours, unlimited paid leave and sick time, a 401(k) plan with employer matching, healthcare, vision, dental, and life insurance plans for employees and their dependents, a flexible spending account with employer contribution, generous parental leave, a supportive culture that respects work-life balance, tax-advantaged commuter benefits for public transportation or parking, and a cool and vibrant work environment in the heart of Boston.

DeepCure is a next-generation biotech company using AI-driven drug discovery to develop novel, first-in-class precision therapeutics. They aim to accelerate breakthroughs in drug discovery and deliver safer and more efficacious therapeutics that are extremely unlikely to be discovered by traditional drug discovery pipelines.

DeepCure fosters an innovative, startup culture where employees are encouraged to think outside the box and contribute to solving challenging problems. They prioritize diversity and collaboration, valuing the unique perspectives and contributions of each team member. Their culture is driven by a shared goal of helping to bring innovative new small molecule drugs to patients faster, while prioritizing curiosity, learning, and continuous improvement.

DeepCure fosters a culture of innovation and collaboration, emphasizing the value of diverse perspectives. They are committed to building a company where every employee feels welcome, respected, and empowered to contribute their unique talents. This commitment is reflected in their values, which highlight the importance of inclusivity, problem-solving, and a shared goal of bringing new medicines to patients. DeepCure actively seeks out individuals with diverse backgrounds and experiences, recognizing that a varied team leads to better solutions and greater success.